How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

Signal to Noise versus Titer: Is it time to adopt a new paradigm for clinical immunogenicity assessment?

calendar_today September 28, 2026 person Celerion domain celerion-hig-capital

After a busy spring and summer season of bioanalytical conferences, we are gearing up for a full schedule this fall. From EIP in Portugal to WRIB in Texas and SSF in Ohio, Celerion’s scientific leaders have spent countless hours engaged with others in the bioanalytical community this year and have found a now-familiar topic being […] The post Signal to Noise versus Titer: Is it time to adopt a new paradigm for clinical immunogenicity assessment? first appeared on Celerion .

open_in_new Read original post